If You Invested $10,000 in Livongo Health’s IPO, This Is How Much Money You’d Have Now

Livongo Health (NASDAQ:LVGO) stands out as one of the stocks that have benefited tremendously from the COVID-19 pandemic this year. The company’s digital health platform helps individuals manage chronic conditions like diabetes and hypertension. With the pandemic increasing the need for remote health monitoring and personalized healthcare, Livongo was in the right place at the right time.

Some investors were also in the right place at the right time by buying Livongo shares at the company’s initial public offering last year. They’ve won big from the rise of the healthcare stock in 2020. Here’s how much you would have now if you’d invested $10,000 in Livongo Health’s IPO.

Smiling woman holding a smartphone with images of dollar signs over it.

Image source: Getty Images.

Counting the cash

If you’d been able to buy at Livongo’s IPO price of $28, an initial investment of $10,000 would have given you 357 shares. If we assume you didn’t buy partial shares, you would’ve had a

Read More

If You Invested $10,000 in Guardant Health’s IPO, This Is How Much Money You’d Have Today

I was a little late to the party in buying Guardant Health (NASDAQ:GH). After watching the stock soar during the latter part of 2018 and the first half of 2019, I finally jumped in to scoop up shares in July of last year. I’m glad I did.

But do I regret missing out on investing in Guardant Health at its initial public offering (IPO)? Yep. If you didn’t get in on the IPO, you might already share the same regret (at the very least, you soon will). Here’s how much you’d have today if you had invested $10,000 in Guardant Health’s IPO.

Five increasingly higher stacks of coins with blocks spelling out IPO on the three highest stacks and a businessman holding a red line trending up in the background

Image source: Getty Images.

A huge winner

Some IPO stocks rise quickly but then the gains evaporate. Not Guardant Health. It’s been a huge winner since day one.

Guardant Health operated as a privately held company for roughly six years before listing its shares on the Nasdaq

Read More